Arkolith/Insider Trading/BLCM/Form 4

Daly James M

DirectorBELLICUM PHARMACEUTICALS, INC (BLCM) · full profile →Form 4 · filed Jan 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 4, 2022Option exercise(M)809—$014K
Jan 4, 2022Option exercise(M)14K—$014K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 4, 2022Option exercise(M)809—$00
Jan 4, 2022Option exercise(M)14K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-000412) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML